JNJ is down 0.45% today in the Healthcare sector. Volume is 0.
Johnson & Johnson proposed a $5.5b settlement to resolve tens of thousands of ovarian cancer talc lawsuits. The offer aims to address a decade-long legal dispute involving the com…
CAMBRIDGE, Mass., July 29, 2026--Sail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T
NEW BRUNSWICK, N.J., July 29, 2026--Johnson & Johnson (NYSE: JNJ) today announced the successful completion of its acquisition of Firefly Bio, Inc., a biotechnology company advanc…
NEW BRUNSWICK, N.J., July 29, 2026--Johnson & Johnson1 (NYSE: JNJ) today announced strategic agreements and collaboration with Sail Biomedicines (Sail), a biotechnology company de…
But is that performance sustainable?